Brief: HLS Therapeutics Announces Second Quarter Fiscal 2021 Financial Results
05/08/2021 13:29
Aug 5 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS ANNOUNCES SECOND QUARTER FISCAL 2021
FINANCIAL
RESULTS
* Q2 REVENUE $14.9 MILLION VERSUS $12.6 MILLION
* Q2 LOSS PER SHARE $0.07
Source text for Eikon: ID:nCNWyRjSla
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsCanada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group
Canada's HLS Therapeutics Q1 revenue rises on Vascepa growth, reaffirms 2026 guidance
Canada's HLS Therapeutics Q4 revenue slightly beats on Vascepa strength
Brief: Esperion Partner announces HLS Therapeutics received approval Of NILEMDO for the reduction of LDL-cholesterol in canadians at risk of cardiovascular disease
Brief: HLS Therapeutics announces Health Canada approval of NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease